Meet the Analyst

Arron Aatkar, PhD

Analyst

Healthcare

Arron joined Edison’s healthcare team as an equity analyst in January 2023 and has covered over 30 companies within the sector since joining. Prior to this, he worked at GSK for four years and completed a PhD in chemical biology through the GSK/University of Strathclyde Collaborative PhD Programme. During this time, he conducted extensive research into novel therapeutic technologies, with a particular focus on covalent drug discovery, oncology, and various rare diseases.

Arron also holds an integrated MSci degree in chemistry from the University of Bristol.

From the Analyst

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.